MENU
+Compare
IFRX
Stock ticker: NASDAQ
AS OF
Jun 30, 04:49 PM (EDT)
Price
$0.79
Change
-$0.02 (-2.47%)
Capitalization
54.73M

IFRX InflaRx NV Forecast, Technical & Fundamental Analysis

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR... Show more

Industry: #Biotechnology
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IFRX with price predictions
Jun 27, 2025

IFRX's RSI Indicator recovers from oversold territory

The RSI Indicator for IFRX moved out of oversold territory on June 18, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 27, 2025. You may want to consider a long position or call options on IFRX as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IFRX just turned positive on June 23, 2025. Looking at past instances where IFRX's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

IFRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 87 cases where IFRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

IFRX moved below its 50-day moving average on May 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IFRX crossed bearishly below the 50-day moving average on June 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.664) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). IFRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (322.581) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IFRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IFRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IFRX is expected to report earnings to rise 34.08% to -17 cents per share on July 31

InflaRx NV IFRX Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.16
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
The last earnings report on May 07 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 64.80K shares outstanding, the current market capitalization sits at 54.73M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDEIY10.790.11
+1.03%
Redeia Corporacion SA
CRZY30.12N/A
N/A
Crazy Woman Creek Bancorp Inc.
HINOF2.54N/A
N/A
Hino Motors Ltd.
JWCTF0.25N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.
CNLTN32.50N/A
N/A
Connecticut Light & Power Co. (The)

IFRX and Stocks

Correlation & Price change

A.I.dvisor tells us that IFRX and LXEO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and LXEO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
-2.98%
LXEO - IFRX
29%
Poorly correlated
-1.44%
RCUS - IFRX
28%
Poorly correlated
-6.47%
VERA - IFRX
28%
Poorly correlated
-2.75%
NMRA - IFRX
26%
Poorly correlated
-5.32%
ARWR - IFRX
26%
Poorly correlated
+0.06%
More